IL1B and Alzheimer disease: A pathogenic role for IL‐1β in AD has been demonstrated in mice with a deficiency in IL‐1 receptor antagonist (IL‐1ra), which resulted in increased vulnerability to intracerebroventricular injection with human oligomeric Aβ1–42 (Craft et al, 2005).